review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.7326/0003-4819-101-6-825 |
P698 | PubMed publication ID | 6388454 |
P2093 | author name string | Goldman L | |
Cook EF | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart disease | Q190805 |
coronary artery disease | Q844935 | ||
P304 | page(s) | 825-836 | |
P577 | publication date | 1984-12-01 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle | |
P478 | volume | 101 |
Q33615616 | 'Ruling out' myocardial infarction in the coronary care unit |
Q33873042 | 31st Bethesda Conference. Emergency Cardiac Care. Task force 1: cardiac arrest |
Q68047602 | A comparison of results of a national cholesterol and blood pressure screening with the NHANES II Study: implications for further emphasis on reducing cardiovascular risk among Americans |
Q39606710 | A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention |
Q73498740 | A population-based approach to cholesterol control |
Q33559037 | A public health approach to cholesterol. Confronting the 'TV-auto-supermarket society'. |
Q33548515 | A review of five major community-based cardiovascular disease prevention programs. Part I: Rationale, design, and theoretical framework. |
Q33616750 | A woman's heart. An update of coronary artery disease risk in women |
Q44437511 | ATP-Sensitive Potassium Channel Traffic Regulation by Adenosine and Protein Kinase C |
Q58432502 | Advancing analytic epidemiologic studies of occupational injuries |
Q50632678 | An age-related difference in the ratio of sudden coronary death over acute myocardial infarction in Estonian males. |
Q40482679 | An update on coronary risk factors |
Q42127634 | Analyzing the decline in the CAD death rate |
Q41154173 | Antioxidants, atherosclerosis and thrombosis. |
Q44428785 | Are increases in treatment levels and Alcoholics Anonymous membership large enough to reduce liver cirrhosis rates? |
Q41386366 | Barriers to lifestyle change, and the need to develop an integrated approach to prevention |
Q68919113 | Blaming the victim: the negative consequence of preventive medicine |
Q39281447 | Cardiovascular care in the urban melting pot. |
Q53224795 | Cardiovascular disease and global health equity: lessons from tuberculosis control then and now. |
Q35372621 | Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions |
Q34032682 | Cardiovascular disease: risk factors in older Canadians. |
Q68444710 | Cardiovascular risks: New insights from Framingham |
Q35010759 | Care models and associated outcomes in congenital heart surgery |
Q26861748 | Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States |
Q24530105 | Changing heat-related mortality in the United States |
Q50651261 | Changing patterns of coronary heart disease in the hunter region of New South Wales, Australia. |
Q30607849 | Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality |
Q33725005 | Choosing quality of care measures based on the expected impact of improved care on health |
Q34191507 | Clinical Evidence: Emerging approaches in preventing cardiovascular disease. |
Q36952970 | Clinical considerations regarding treatment of hypercholesterolemia in the elderly |
Q73512446 | Comment: Gunsmoke--changing public attitudes toward smoking and firearms |
Q71551106 | Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysis |
Q33718012 | Consequences of variation in treatment for acute myocardial infarction |
Q35371795 | Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 |
Q27012592 | Contributions of risk factors and medical care to cardiovascular mortality trends |
Q42285070 | Convergence and divergence of life expectancy in Europe: a centennial view |
Q57421301 | Coronary Heart Disease and Hypertension |
Q36783038 | Coronary artery disease. The latest on prevention |
Q68720858 | Coronary heart disease in Massachusetts: the years of change (1980-1984) |
Q46610981 | Coronary risk factors in adult children of parents with coronary heart disease: a comparison survey of southeastern Brazil and southeastern United States |
Q67597163 | Correlates of nonadherence to hypertension treatment in an inner-city minority population |
Q41740403 | Cost-effective strategies for the management of vascular disease |
Q37581209 | Cost-effectiveness perspectives in coronary heart disease |
Q37808517 | Costs and benefits of risk factor reduction for coronary heart disease: insights from screening and treatment of serum cholesterol |
Q40424562 | Cost‐effectiveness of alternative interventions for the prevention and treatment of coronary heart disease |
Q44793509 | Current status of cholesterol treatment in the community: The Minnesota heart survey |
Q35185829 | Death of a heart surgeon: reflections on press accounts of the murder of Victor Chang |
Q35696678 | Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. |
Q40656464 | Declining cardiovascular disease incidence and environmental components |
Q73578234 | Decreasing mortality from acute myocardial infarctions: effect of attack rates and case severity |
Q35002144 | Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008. |
Q68470624 | Detection and treatment of hypercholesterolemia in a biethnic community, 1979–1985 |
Q43818392 | Development of a structural equation model for causal relationships among arteriosclerosis risk factors |
Q94278450 | Dietary Fats and Coronary Heart Disease |
Q67768154 | Dietary factors in the fall in coronary heart disease mortality |
Q67945486 | Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States |
Q33717288 | Do cardiologists have higher thresholds for recommending coronary arteriography than family physicians? |
Q42579997 | Does modern medicine increase life-expectancy: Quest for the Moon Rabbit? |
Q71716426 | Effect of a postdischarge education class on coronary artery disease knowledge and self-reported health-promoting behaviors |
Q39728963 | Elevated blood pressure in urban emergency department patients |
Q40538399 | Enlightened individual choice vs the public's health: rational prevention from whose perspective? |
Q72702173 | Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure |
Q58390921 | Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations |
Q39654319 | Ethnicity, socio-economic position and gender--do they affect reported health-care seeking behaviour? |
Q33633505 | Evidence based cardiology: emerging approaches in preventing cardiovascular disease |
Q33606250 | Evidence links increases in public health spending to declines in preventable deaths |
Q40721049 | Exercise and aging. Issues for the practitioner |
Q34379641 | Exercise rehabilitation of older patients with cardiovascular disease |
Q57747446 | Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997 |
Q84242169 | Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000 |
Q69414455 | Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model |
Q37001580 | Future non-invasive imaging to detect vascular plaque instability and subclinical non-obstructive atherosclerosis |
Q46616464 | Gender differences in coronary angiographic findings from 1972 through 1981 in Los Angeles, California |
Q69801856 | Geographic variation in the onset of decline of male ischemic heart disease mortality in The Netherlands |
Q68516033 | Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias |
Q47280659 | Health behavior changes in the United States, the United Kingdom, and France |
Q54937459 | Heart Disease Death Rates Among Blacks and Whites Aged ≥35 Years - United States, 1968-2015. |
Q33717229 | Heart disease and hospital deaths: an empirical study |
Q34784496 | Hypertension as a risk factor for developing depressive symptoms among community-dwelling elders. |
Q39903286 | Impact of State Public Health Spending on Disease Incidence in the United States from 1980 to 2009. |
Q43470619 | Implications of a Nicotine-Free Society |
Q35717087 | Improved prognosis since 1969 of myocardial infarction treated in a coronary care unit: lack of relation with changes in severity |
Q38518073 | Incidence and case fatality rates of acute myocardial infarction (1975–1984): The Worcester Heart Attack Study |
Q36837451 | Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. |
Q24289253 | Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research |
Q46880764 | Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains |
Q36674340 | Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? |
Q39263828 | Ischaemic heart disease among men in Norway during the period 1966-1985: two counties with different mortality time trends |
Q33705561 | Ischaemic heart disease mortality among men in Norway: reversal of urban-rural difference between 1966 and 1989 |
Q43878234 | Ischemic heart disease prevention: Estimating the impact of interventions |
Q34032688 | Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. |
Q68394192 | Lengths of stay of patients with uncomplicated acute myocardial infarction at three Boston hospitals: impact of pre-discharge tactics |
Q44520744 | Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? |
Q61192550 | Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000 |
Q68603066 | Long-term impact of smoking cessation on the incidence of coronary heart disease |
Q30377539 | Long-term trends in cardiovascular disease mortality and association with respiratory disease. |
Q37301547 | Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study |
Q44775671 | Major differences in cardiovascular risk indicators by educational status. Results from a population based screening program |
Q43998492 | Management of mild hypertension |
Q33558825 | Management of mild hypertension. Selecting an antihypertensive regimen |
Q34282509 | Medical management and the decline in mortality from coronary heart disease |
Q33789111 | Medical treatment of the aorta. II. |
Q39477119 | Medicine matters after all |
Q94278535 | Modern Times |
Q28142616 | Mortality and morbidity attributable to use of addictive substances in the United States |
Q34405248 | Mortality and morbidity trends: is there compression of morbidity? |
Q33673284 | Mortality risks in alcoholism and effects of abstinence and addiction treatment |
Q34725347 | Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group |
Q39746267 | Noninvasive tests for diagnosing the presence and extent of coronary artery disease: exercise electrocardiography, thallium scintigraphy, and radionuclide ventriculography |
Q46984994 | Nutrition knowledge and attitudes of cardiac patients |
Q34107618 | Nutritional interventions in cardiovascular disease: new challenges and opportunities |
Q74622208 | Nutritional interventions to reduce cardiovascular disease: individual versus population perspectives |
Q33645696 | Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease |
Q46103477 | Polarities in medicine |
Q41715879 | Prehospital delay in patients with acute coronary heart disease: concordance between patient interviews and medical records |
Q38357890 | Prehypertension--prevalence, health risks, and management strategies |
Q37799421 | Prehypertension: An Opportunity for a New Public Health Paradigm |
Q37262225 | Prehypertension: risk stratification and management considerations |
Q37362757 | Prehypertension: should we be treating with pharmacologic therapy? |
Q34032695 | Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992 |
Q68162582 | Prevention of cardiovascular disease in the elderly |
Q74018424 | Primary care physicians and coronary heart disease prevention: a practice model |
Q44106401 | Program on the surgical control of the hyperlipidemias (POSCH): Patient entry characteristics |
Q43554968 | Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study |
Q90737206 | Provincial health expenditure and cardiovascular disease mortality, a panel data study of Canadian provinces |
Q42259772 | Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. |
Q40734450 | Recent time trends in acute myocardial infarction in Stockholm, Sweden |
Q41529254 | Recent trends in acute care hospital utilization in Ontario for diseases of the circulatory system |
Q36283171 | Reducing the Risk of Coronary Artery Disease: Helping patients change |
Q58179005 | Relationship Between Risk Factor Trends and Disease Trends |
Q86677956 | Relationship of self-effecacy to cholesterol lowering and dietary change in hyperlipidemia |
Q43758541 | Relative importance of improved hospital treatment and primary prevention. Results from 20 years of the Myocardial Infarction Register, Göteborg, Sweden |
Q41723391 | Risk factors for coronary heart disease in women |
Q33786237 | Screening for cardiovascular disease. Concepts, conflicts, and consensus |
Q43177508 | Seasonal changes in mortality rates from main causes of death in Japan (1970--1999). |
Q75287379 | Secular decrease in blood pressure and reduction in mortality from cardiovascular disease in Israeli workers |
Q26851295 | Shared care--is it worth it for the patient? |
Q33560221 | Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease |
Q38764672 | Smoking: human and economic costs |
Q37808776 | Stagnant in cardiovascular prevention: alarming trends and persistent socioeconomic obstacles. |
Q35411223 | Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels |
Q41268248 | Task force III: Major demographic and epidemiologic trends affecting adult cardiology |
Q47967777 | Temporal Associations Between Smoking and Cardiovascular Disease, 1971 to 2006 (from the Framingham Heart Study). |
Q34761652 | Temporal trend analysis of avoidable mortality in Taiwan, 1971-2008: overall progress, with areas for further medical or public health investment |
Q33821081 | Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study) |
Q35621407 | The War on Poverty's Experiment in Public Medicine: Community Health Centers and the Mortality of Older Americans |
Q53614601 | The contribution of medical care to mortality decline: McKeown revisited. |
Q52937784 | The decline and rise of coronary heart disease: understanding public health catastrophism. |
Q68327122 | The decline in coronary mortality and medical care: some additional questions |
Q34700621 | The economics of diabetes prevention |
Q51572952 | The effect of age on cardiovascular risk factors in Chinese women. |
Q34215500 | The genetics of atherothrombotic disorders: a clinician's view |
Q35920789 | The health consequences of smoking. Cardiovascular diseases |
Q33401729 | The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. |
Q34102249 | The impact of preventive cardiology on coronary artery disease |
Q72933701 | The investigation and management of stable angina. Report of a working party of the Joint Audit Committee of the British Cardiac Society and the Royal College of Physicians of London |
Q69584316 | The maturation of a cardiologist with reflections on the "passing sands of time" |
Q33855756 | The prevalence and prognostic significance of electrocardiographic abnormalities |
Q39540365 | The rise and fall of ischemic heart disease in Australia |
Q33809060 | The role of coronary angioplasty and stenting in acute myocardial infarction |
Q53454652 | The role of medical care in contributing to health improvements within societies. |
Q46510248 | The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies |
Q44745301 | Time trends in the treatment of acute myocardial infarction in Switzerland from 1986 to 1993: do they reflect the advances in scientific evidence from clinical trials? |
Q33701313 | Trends in "avoidable" mortality in Sweden, 1974-1985. |
Q34725940 | Trends in coronary artery bypass grafting in Ontario from 1981 to 1989. |
Q28175989 | Trends in treatment and outcomes for acute myocardial infarction: 1975-1995 |
Q90678493 | US trends in premature heart disease mortality over the past 50 years: Where do we go from here? |
Q33588350 | Update in internal medicine |
Q37391696 | Urban-rural differences in coronary heart disease mortality in the United States: 1999-2009. |
Q73906497 | Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s. Israeli Thrombolytic Survey Group and the Secondary Prevention Reinfarction Isr |
Q35030744 | Vitamin E in cardiovascular disease: has the die been cast? |
Q34068636 | What contribution has cardiac surgery made to the decline in mortality from coronary heart disease? |
Q70335693 | What contribution has cardiac surgery made to the decline in mortality from coronary heart disease? |
Search more.